Prp8 protein (Prp8p) is a highly conserved pre-mRNA splicing factor and a component of spliceosomal U5 small nuclear ribonucleoproteins (snRNPs). Although it is ubiquitously expressed, mutations in the C terminus of human Prp8p cause the retina-specific disease retinitis pigmentosa (RP). The biogenesis of U5 snRNPs is poorly characterized. We present evidence for a cytoplasmic precursor U5 snRNP in yeast that lacks the mature U5 snRNP component Brr2p and depends on a nuclear localization signal in Prp8p for its efficient nuclear import. The association of Brr2p with the U5 snRNP occurs within the nucleus. RP mutations in Prp8p in yeast result in nuclear accumulation of the precursor U5 snRNP, apparently as a consequence of disrupting the interaction of Prp8p with Brr2p. We therefore propose a novel assembly pathway for U5 snRNP complexes that is disrupted by mutations that cause human RP.
Prp8 protein (Prp8p) is a highly conserved pre-mRNA splicing factor and a component of spliceosomal U5 small nuclear ribonucleoproteins (snRNPs). Although it is ubiquitously expressed, mutations in the C terminus of human Prp8p cause the retina-specific disease retinitis pigmentosa (RP). The biogenesis of U5 snRNPs is poorly characterized. We present evidence for a cytoplasmic precursor U5 snRNP in yeast that lacks the mature U5 snRNP component Brr2p and depends on a nuclear localization signal in Prp8p for its efficient nuclear import. The association of Brr2p with the U5 snRNP occurs within the nucleus. RP mutations in Prp8p in yeast result in nuclear accumulation of the precursor U5 snRNP, apparently as a consequence of disrupting the interaction of Prp8p with Brr2p. We therefore propose a novel assembly pathway for U5 snRNP complexes that is disrupted by mutations that cause human RP.
Nuclear pre-mRNA splicing is an essential housekeeping process in all eukaryotic cells. It is catalyzed by a large ribonucleoprotein complex called the spliceosome, which contains the snRNPs U1, U2, U4, U5 and U6, as well as many non-snRNP proteins 1, 2 . Each snRNP consists of an snRNA, a set of specific proteins, and seven common Sm proteins (or, in the case of U6 snRNP, seven Lsm proteins).
Unexpectedly, mutations in four human snRNP-associated proteins-PRPF8 (ref. 3) , PRPF31 (ref. 4) , PRPF3 (ref. 5 ) and PAP-1 (also called RP9) (refs. 6,7)-were found in people with a dominantly inherited form of retinal degeneration: RP. Here, we investigate the role of Prp8p (the yeast ortholog of PRPF8) in U5 snRNP biogenesis in Saccharomyces cerevisiae, and the effect of RP mutations on this process.
Biogenesis of the U snRNPs has been studied extensively in metazoans 1, 8 . The U1, U2, U4 and U5 snRNAs are produced as precursors in the nucleus by RNA polymerase II and then exported to the cytoplasm, which is facilitated by nuclear cap-binding proteins and the export factors CRM1 and PHAX (ref. 8) . In the cytoplasm, the binding of the Sm proteins, which is facilitated by the SMN complex 9, 10 , and hypermethylation of the m 7 G cap to form a 2,2,7-trimethylguanosine (m 3 G) cap 1 generates a bipartite nuclear localization signal (NLS). Import of this core snRNP to the nucleus is mediated by the SMN complex, importin-b and snurportin-1 (ref. 11). Association of snRNP-specific proteins with the core particles is required to produce mature snRNPs. Several U1-and U2-specific proteins are imported to the nucleus independently of their cognate snRNAs, and they associate with core snRNPs in nuclear Cajal bodies [12] [13] [14] [15] . It is not known at what stage the U5-specific proteins associate with the core snRNP. The biogenesis of U snRNPs in yeast is less well characterized. No orthologs of PHAX or Snurportin-1 have been identified in S. cerevisiae 11, 16 , which indicates that the nuclear export and re-import pathways may not exist in yeast.
Prp8p is a large (274 kDa in humans) U5 snRNP-specific protein that is highly conserved in both sequence and size (reviewed in ref. 17) . It is essential for pre-mRNA splicing 18 and is produced in all mammalian tissues 19 3, [20] [21] [22] [23] [24] . These mutations are clustered at the C terminus of the protein in a conserved region within the last exon.
In budding yeast, Prp8p associates with U5 snRNA in two complexes. The simpler Aar2-U5 snRNP (ref. 25) consists of Prp8p, Snu114p, Aar2p, Sm proteins and U5 snRNA. The larger U5 snRNP (ref. 26 ) lacks Aar2p but instead contains Brr2p, Prp28p, Snu40p and Dib1p. It has been suggested that the Aar2-U5 snRNP might represent an intermediate particle in U5 snRNP biogenesis 25 . Here, we identify a functional NLS in Prp8p and show that in its absence the Aar2-U5 snRNP seems to accumulate in the cytoplasm. In contrast, the nuclear accumulation of Brr2p, a specific component of the larger U5 snRNP, is unaffected. A similar analysis in yeast carrying prp8 mutations that cause RP in humans also shows an increase in the Aar2-U5 snRNP; however, RP Prp8p proteins accumulate in the nucleus. We therefore propose a model for U5 snRNP biogenesis and a molecular basis for a splicing defect caused by mutations that lead to RP in humans.
RESULTS
Evidence for a cytoplasmic U5 snRNP A putative NLS was identified at amino acids 96-117 of Prp8p of S. cerevisiae within a region rich in basic amino acids that is conserved in most eukaryotes 17 . Codons 96-117 of PRP8 were deleted from plasmid pJU204 (ref. 27 ) to produce pKLDNLS (prp8DNLS-3HA), and these plasmids were introduced into yeast strains KL1 and KL3 (Supplementary Table 1 online), in which the chromosomal P GAL1 -PRP8 is strongly repressed in glucose medium. pKLDNLS supported only slow growth of these cells on glucose (4.5 h doubling time; data not shown). Immunofluorescent staining of cells showed that full-length Prp8p localizes to the nucleus, whereas DNLS-Prp8p is present in both nucleus and cytoplasm (Fig. 1a) . When Prp8p 96-117 was fused to the N terminus of green fluorescent protein (GFP), this caused the GFP-NLS fusion protein to accumulate in nuclei (Fig. 1b) , which confirms that this region of yeast Prp8p contains a functional NLS. As there was sufficient nuclear DNLS-Prp8p protein to support cell viability, albeit with very slow growth, there may be another NLS that allows inefficient nuclear uptake of this very large protein.
Candidates include another cluster of basic residues in the N-terminal portion of Prp8p (ref. 17) or, by analogy with metazoan systems, the m 3 G cap of U5 snRNA and/or the Sm proteins SmB and SmD1, which also have NLSs 28 .
Next, pJU204 or pKLDNLS was introduced into yeast strains KL1-Aar2, KL1-Brr2p and KL1-Snu114 (in which the indicated protein is tandem affinity purification (TAP)-tagged), and the tagged proteins were observed microscopically. In strains with full-length Prp8p, the localization of Snu114p and Brr2p was nuclear, whereas Aar2p was present in both nucleus and cytoplasm (Fig. 1c-e) . In strains with DNLS-Prp8p, Snu114p was delocalized, with a substantial amount present in the cytoplasm (Fig. 1c) , whereas Brr2p was consistently nuclear (Fig. 1d) . The cytoplasmic staining of Aar2p was also slightly increased with DNLS-Prp8p (Fig. 1e ), but this effect was difficult to assess. However, when Prp8p was overexpressed, Aar2p became concentrated in the nucleus, whereas upon Prp8p depletion Aar2p was observed throughout the cells (Fig. 1f) . This suggests that the nuclear accumulations of Prp8p and Aar2p are linked; Prp8p might mediate the nuclear accumulation of Aar2p, or vice versa.
Prp8p is a component of U4/U6-U5 tri-snRNPs and of free U5 snRNPs. Importantly, DNLS-Prp8p coprecipitated the U5 snRNAs almost as efficiently as did full-length Prp8p, but it coprecipitated less U4 and U6 snRNAs (50%-60% relative to full-length Prp8p; Supplementary Fig. 1a online) , which suggests a defect in the incorporation of DNLS-Prp8p into tri-snRNPs. Such a defect may occur as a consequence of defective U5 snRNPs or fewer U5 snRNPs in the nucleus. Extract prepared from glucose-grown KL1 cells that depend on DNLS-Prp8p for viability also showed a lower splicing activity ( Supplementary Fig. 1b) , which may be caused by the reduced level of tri-snRNPs.
As the U5 snRNAs seemed to be associated as efficiently with DNLS-Prp8p as with full-length Prp8p, despite DNLS-Prp8p being distributed throughout the cells, we investigated the localization of U5 snRNA. RNA fluorescent in situ hybridization (FISH) showed that U5 snRNA was predominantly nuclear in the presence of full-length Prp8p but gave a substantial cytoplasmic signal in the DNLS-Prp8p strain (Fig. 1g) . It is therefore likely that DNLS-Prp8p is associated with U5 snRNA in the cytoplasm and in the nucleus. In contrast, U2 snRNA was nuclear in both strains (Fig. 1h) , as was U6 snRNA (data not shown).
Distinct Aar2-and Brr2p-U5 snRNPs In biochemical studies, human Brr2p was found stably associated with human Prp8p in the absence of RNA 29 . However, a U5 RNP complex has been identified 25 that contains Prp8p and Aar2p but not Brr2p. Indeed, we found that TAP-tagged Prp8p pulls down Aar2p (Fig. 2a) , but that TAP-tagged Brr2p does not coprecipitate Aar2p from extract containing either wild-type (WT) Prp8p or DNLS-Prp8p (Fig. 2a) .
We analyzed the distribution of Aar2p, Brr2p and Snu114p in Prp8p-associated complexes using a combination of glycerol gradient centrifugation and anti-HA (hemagglutinin) immunoprecipitation of extracts from KL3-Brr2p cells expressing either full-length Prp8-3HAp or DNLS-Prp8-3HAp. Gradient fractions were incubated with anti-HA agarose, and the precipitates were analyzed by western blot for the presence of Brr2p-13Myc, Snu114p and Aar2p. The results show that DNLS-Prp8p coprecipitated more Aar2p and less Brr2p than did WT Prp8p (Fig. 2) . With WT Prp8p, Snu114p was more concentrated in the bottom fractions (Fig. 2b) , which contained the Prp8-associated Brr2p but little or no Aar2p. In contrast, with DNLS-Prp8p, Snu114p was more evenly distributed between the fractions containing Brr2p and Aar2p (Fig. 2c) . Thus, the DNLS-Prp8p extract contained more Prp8p-Snu114p-Aar2p complex and less Prp8p-Snu114p-Brr2p complex than the WT. The association of U5 snRNA with the Aar2p complex was investigated in cell extracts from KL1-Aar2 containing either Prp8p or DNLS-Prp8p. An increased amount of U5 snRNA coprecipitated with Aar2p from extract containing DNLS-Prp8p compared with fulllength Prp8p (Fig. 2d) . This supports the conclusion from the gradient fractionation experiment that the level of Aar2p-U5 snRNP complex increased when nuclear accumulation of Prp8p was hindered.
Thus, the existence of two distinct Prp8p complexes 25, 26 is supported by our finding that Prp8p was associated independently with Brr2p or with Aar2p in different glycerol gradient fractions, and that Brr2p did not pull down Aar2p. Furthermore, the glycerol gradient results showing that the prp8DNLS mutation increased the amount of Aar2p-Prp8p complex and decreased the amount of Brr2p-Prp8p complex suggest that these complexes may be in equilibrium. The presence of U5 snRNA in a cytoplasmic Aar2-Prp8p complex is suggested by the delocalization of U5 snRNA and the association of more Aar2p with U5 snRNA and with Prp8p in prp8DNLS cells. Also, although DNLS-Prp8p is substantially delocalized to the cytoplasm, it is nevertheless associated with a similar amount of U5 snRNA compared to full-length Prp8p. We therefore propose that there is a cytoplasmic Aar2-Prp8p-Snu114-U5 snRNP complex that, once imported to the nucleus, is in equilibrium with the Brr2p-Prp8p-Snu114-U5 mature snRNP complex.
The existence of a U5 precursor that lacks Brr2p raises the question as to whether there is a separate pool of Brr2p that is not Prp8p-associated, or whether Brr2p may be limiting in yeast cells. To investigate this, cell extract containing Brr2p-TAP and untagged Prp8p was analyzed by glycerol gradient fractionation, precipitation with IgG-agarose and western blot with anti-Snu114p antibodies. Notably, two peaks of Brr2p were found, one at the bottom of the gradient (Fig. 3a) that coprecipitates Snu114p, and another in lighter fractions ( Fig. 3a) that does not coprecipitate Snu114p. Stripping the blot and reprobing with anti-Prp8p antibodies showed that Prp8p is associated with Brr2p only in the heavier fractions (1 to 11, not shown), which is in agreement with the Prp8p pull-down of Brr2p (Fig. 2b) . Thus, in addition to the Brr2p that is complexed with Prp8p and Snu114p in mature U5 snRNPs, there is a pool of Brr2p that is not associated with either Snu114p or Prp8p. Future studies should determine whether the latter form of Brr2p is complexed with other proteins, such as the U5 snRNP proteins Snu40p, Prp28p and Dib1p.
The proposal that the Aar2p-Prp8p complex is in equilibrium with the Brr2p-Prp8p complex also predicts that this equilibrium might be disturbed by altering the availability of Brr2p. To test this, we constructed strain RG-MetB2-8T, in which expression of BRR2 is repressed by methionine and Prp8p is TAP-tagged. Addition of methionine to the growth medium causes cell growth to slow substantially after about 10 h (Fig. 3b) as a consequence of Brr2p depletion. Prp8p-TAP precipitation followed by western blot showed that at 6.5 and 10 h following addition of methionine, as Brr2p became depleted, less Brr2p and more Aar2p was coprecipitated with Prp8p-TAP, whereas the amount of Snu114p associated with Prp8p-TAP was similar (Fig. 3c) . This strongly supports an equilibrium between the Aar2p-Prp8p and Brr2p-Prp8p complexes.
U5 snRNP maturation and RP
As all of the RP-causing mutations affect amino acids in the extreme C terminus of human Prp8p, a region that is highly conserved from yeast to human, we investigated the effects of some of these mutations in the budding yeast Prp8p. Seven missense mutations were tested, each changing an amino acid that is identical in human and budding yeast Prp8p. We previously demonstrated a two-hybrid interaction between Brr2p and the C terminus of Prp8p (ref. 30 ). This interaction was disrupted by the yeast prp8-1 mutation, which affects the same region of Prp8p as the RP mutations 30 . We therefore used an in vitro binding assay to investigate the effects of seven missense RP mutations 3 (referred to hereafter as rp1-rp7; Fig. 4a ) on the association of a C-terminal Prp8p peptide with Brr2p. Yeast Prp8p 2,210-2,413 was identified as the minimum region for the interaction with Brr2p, although the interaction was strengthened with a longer peptide ( Supplementary Fig. 2 online) . The 35 S-methionine-labeled 204 amino acid peptides were produced by in vitro translation and incubated with yeast cell extract containing full-length Myc-tagged Brr2p and anti-Myc antibodies. Relative to the WT Prp8p peptide, all seven prp8-rp mutations that were tested reduced or eliminated the association with Brr2p (Fig. 4b) . Similarly, researchers recently used a two-hybrid assay in yeast to show that some of the same RP mutations when present in the C terminus of human Prp8p disrupt its interaction with human Brr2p and/or with human Snu114 (ref. 31). Thus, the molecular defects caused by the RP mutations may be conserved from yeast to humans.
We then created yeast strains that express these seven prp8-rp alleles by introducing the mutations either into the chromosomal PRP8 gene or into PRP8 on a plasmid in a strain in which the chromosomal gene is fully repressed in glucose medium. The rp strains made by the two approaches gave similar results. The rp1 (P2379T), rp2 (F2382L), rp3 (H2387R) and rp4 (H2387P) mutant strains behaved in an unstable manner, showing variable colony sizes, and the rp3 and rp4 mutants failed to grow at 37 1C. The rp5 (R2388K) and rp6 (R2388G) alleles supported good growth at 23 1C but poor or no growth at higher and lower temperatures, whereas rp7 (F2392L) caused a mild growth defect at 14 1C to 18 1C. As the rp5, rp6 and rp7 mutants showed more stable phenotypes, they were selected for further analysis. The presence of the 3HA tag at the C terminus of Prp8p exacerbated the growth defects of the rp mutants relative to untagged rp alleles (data not shown; also, A. Kutach and C. Guthrie, University of California, San Francisco, personal communication). This is notable in view of the fact that one of the reported RP mutations alters the stop codon of human PRPF8, thereby extending the open reading frame by 41 amino acids 20 . Although the addition of a C-terminal 3HA tag does not cause an obvious growth or splicing defect with WT yeast Prp8p, it may enhance the RP phenotype of prp8-rp mutants by effectively combining two rp alleles. The extended sequence might further weaken the interaction of the C terminus of Prp8p with Brr2p, when it is already weakened by the rp1-rp7 point mutations. In all experiments the tagged mutants were compared with tagged WT. However, the C-terminal peptide used in the in vitro pull-down experiment (Fig. 4b) was not tagged. When extracts from prp8-rp5 cells were tested for the ability to splice in vitro, the rate of ACT1 pre-mRNA splicing was slower than in WT extracts (Fig. 4c) . In addition, there was a severe splicing defect when reactions were incubated at both lower and higher temperatures ( Supplementary Fig. 3 online) . Thus the in vitro splicing activity showed the same heat and cold sensitivity as growth of the prp8-rp5 mutant cells. RT-PCR analysis showed a defect in the splicing of ACT1 transcripts in vivo in rp5 and rp6 cells grown at 30 1C that increased substantially at 37 1C ( Supplementary Fig. 4 online) . In addition, microarray analysis showed a genome-wide splicing defect for rp5 mutant cells incubated at 14 1C or 37 1C and for rp6 mutant cells incubated at 37 1C, which confirms a general splicing defect in vivo ( Supplementary Fig. 5 online) .
To investigate the effect of the rp5 mutation on the association of Prp8p and Brr2p with snRNPs, extracts from WT and rp5 mutant cells were incubated with anti-Prp8p or anti-Brr2p antibodies, and the coprecipitated snRNAs were detected by northern analysis. Mutant and WT Prp8ps were associated with similar levels of U5 snRNAs, but mutant Prp8p brought down less U4 and U6 snRNAs, which indicates a defect in the incorporation of mutant Prp8p into U4/U6-U5 tri-snRNPs (Fig. 4d) . In contrast, Brr2p was associated with less U4, U5 and U6 snRNAs in the mutant compared with the WT, but the difference was more pronounced for the U5 snRNAs (Fig. 4d) . This result is supported by the amounts of snRNAs that were unbound (Fig. 4d) and suggests a defect in the association of Brr2p with U5 snRNA in the mutant strain, with most or all of the mutant U5 snRNPs that do contain Brr2p being incorporated into tri-snRNPs. These results strongly suggest that although the rp5 mutation does not prevent the association of mutant Prp8p with U5 snRNA, it causes a defect in the formation of Brr2p-containing U5 snRNPs, which results in reduced amounts of U4/U6-U5 tri-snRNP complexes, which would explain the reduced splicing efficiency.
Extracts from the prp8-rp mutation strains were fractionated in glycerol gradients followed by immunoprecipitation of Prp8p and western blot analysis. Compared with WT Prp8p (Fig. 4e) , the Prp8p-rp mutant proteins were associated with less Brr2p (Fig. 4f-h ) and more Aar2p (Fig. 4f-h) . Also, in the mutant extracts the distribution of Prp8p-associated Snu114p was different, with less present in the high-density fractions compared with WT. The effect of the prp8-rp5 mutation on Brr2p associations was then investigated in a similar way. Notably, extract from the mutant strain showed more Brr2p in the lighter gradient fractions and less Snu114p coprecipitating with Brr2p from the denser fractions ( Supplementary Fig. 6 online). As expected, no Aar2p was detected in any of the Brr2p precipitates. This supports the conclusion that the prp8-rp5 mutation causes reduced incorporation of Brr2p into U5 snRNPs and larger snRNP complexes.
The effects of the prp8-rp mutations on snRNP formation and splicing resemble those of the prp8DNLS mutation. We therefore used immunofluorescence microscopy to investigate the localization of the yeast Prp8p-rp mutant proteins. However, unlike the DNLS-Prp8p, the Prp8p-rp mutant proteins showed no sign of delocalization from the nucleus (data not shown). Thus, unlike the situation with DNLSPrp8p, the Prp8p-Aar2p complex that accumulates in the prp8-rp mutants is nuclear and therefore has the possibility to interact with Brr2p but does so with reduced efficiency as a consequence of the poor association of Brr2p with Prp8p-rp mutant proteins.
DISCUSSION
Our data confirm the existence of two distinct U5 snRNP complexes and suggest that U5 snRNP biogenesis has a cytoplasmic phase in yeast similar to that found in metazoan cells. Although the association of Prp8p with cytoplasmic U5 snRNP precursor particles has not been noted in metazoan cells, considering the high conservation of the U5 snRNP components (especially of Prp8p), it seems likely that the pathway of U5 snRNP biogenesis is also conserved. Indeed, a role for Prp8p in the nuclear uptake of U5 snRNP precursor particles could explain why this process is m 3 G cap-independent in Xenopus sp. oocytes 32 . Within the nucleus, the conversion of U5 precursor to mature U5 snRNP involves substitution of Aar2p at the C terminus of Prp8p by Brr2p, and presumably the acquisition of the other three U5-specific proteins (Prp28p, Snu40 and Dib1p). The rp mutations residing in the C terminus of Prp8p interfere with U5 snRNP maturation in a different manner than the N-terminal DNLS mutation, causing a defect in the interaction of Prp8p with Brr2p and thereby reducing functional U5 snRNP and U4/U6-U5 tri-snRNP formation in the nucleus (Fig. 5) . Although a precursor-product relationship between the Aar2-U5 complex and the Brr2p-U5 snRNP has not been formally demonstrated, such a relationship is strongly suggested by the finding that (i) the amount of Aar2p-Prp8p complex is increased, and the amounts of Brr2p-Prp8p complex and U4/U6-U5 tri-snRNP complex are decreased as a consequence of the prp8DNLS or the prp8-rp mutation, (ii) the amount of a new form of Brr2p that is not Prp8p-associated is increased by the prp8-rp5 mutation and (iii) the metabolic depletion of Brr2p also causes an accumulation of Aar2p-Prp8p complex.
We showed previously 33 that Prp8p 771-2,413 associates with Aar2p and that dissection of Prp8p at residue 2,173 by expressing it as two separate polypeptides disrupts its association with Aar2p. Therefore, Aar2p may interact with the C terminus of Prp8p in close proximity to the region of Brr2p interaction. This suggests a potential model for a competitive interaction of Aar2p and Brr2p with Prp8p. Presumably, Aar2p has an as-yet-unknown but important role in the biogenesis of U5 snRNPs, possibly as a chaperone to control the assembly of the mature particle. Therefore the cytoplasmic location for the formation of the precursor U5 particle may be a critical feature of U5 snRNP biogenesis, ensuring that Aar2p associates with Prp8p before it is exposed to Brr2p in the nucleus. Indeed, there is evidence that the prior binding of Aar2p to a C-terminal fragment of Prp8p inhibits the subsequent association of Prp8p with Brr2p in vitro Figure 5 Cartoon showing the proposed pathway for U5 snRNP biogenesis in budding yeast. Note that the U5 snRNP proteins Prp28p, Snu40p and Dib1p are not shown. Their interactions were not investigated in this work, but based on the reported compositions of the Aar2p-and Brr2p-containing particles 25, 26 , they are assumed to join the U5 snRNP in the nucleus at the same stage as Brr2p. NPC, nuclear pore complex; Sm, a complex of seven core snRNP proteins.
(A. Kutach and C. Guthrie, University of California, San Francisco, personal communication).
These observations support the hypothesis that the rp defect is a consequence of decreased affinity of Brr2p for a mutated C terminus of Prp8p; this decreased affinity results in a defect in the production of mature U5 snRNPs in the nucleus. This further suggests that the normal equilibrium between the Aar2p-U5 complex and the Brr2p-U5 snRNP complex depends, at least in part, on this Prp8p-Brr2p interaction.
The reduced splicing activity in yeast carrying the rp mutations (Fig. 4c) is likely to be a direct consequence of the reduction in the concentration of mature U5 snRNPs. This is presumably the earliest defect in the splicing pathway that is caused by the rp mutations. However, the incorporation of mutant Prp8p into spliceosomes may also affect spliceosome activation by Brr2p and might explain the observed temperature sensitivity of growth and of splicing caused by some of the rp alleles.
Could this reduced splicing activity explain the clinical consequences of RP in humans? The first symptoms of RP are night blindness and loss of peripheral vision, generally beginning in childhood. RP is therefore a late-onset, progressive, degenerative disease rather than a developmental defect. The retina is a complex, specialized, nondividing tissue with high oxygen consumption and an unusually large number of mitochondria, which implies a high metabolic rate (reviewed in ref. 34 ). Rod and cone photoreceptors turn over their outer segments daily, which is likely to require a high level of expression of both retina-specific and housekeeping genes during a particular period early each day. Therefore, a reduced level of splicing activity may have a cumulative effect that has much more serious consequences in these cells than in other tissues.
However, mutations causing human inherited disease have been identified in other components of the splicing machinery 35 , each of which may also cause mild splicing defects, and it is unclear what makes the effect of the rp mutations retina-specific. The fact that these cause a dominant genetic defect in humans may offer a clue. The rp5 and rp6 mutations did not cause a dominant growth defect in heterozygous diploid yeast (data not shown). Therefore, the dominant aspect of the disease may be specific to retinal cells. How could our model explain dominance? The accumulation of the Aar2p-U5 snRNP in the nucleus might cause a dominant defect if it became inappropriately incorporated into tri-snRNPs or spliceosomes. Alternatively, accumulation of defective Aar2p-U5 snRNP might sequester a specific factor required for its conversion to the mature U5 snRNP. Also, this factor may be limiting in retinal cells, or the splicing of certain retinalspecific transcripts may involve a retinal-specific factor (in particular a U5 snRNP or U4/U6-U5 tri-snRNP component) that is more sensitive to this defect. It will be important to further characterize the process of U5 snRNP maturation and the specific function of the Aar2p protein.
In the meantime, the results presented here explain how RP mutations can cause a splicing defect and suggest testable hypotheses for the molecular basis of splicing factor RP in human cells.
METHODS
Yeast strains and plasmids. Yeast strains and plasmids used in this work are listed in Supplementary Table 1. Oligonucleotides are in Supplementary Table 2 online. pKLDNLS was constructed by deleting codons 96-117 via sitedirected mutagenesis of PRP8 in pJU204 (ref. 27) using oligos F-NLS-P8-352 and R-NLS-P8-285. Strain KL1 has a chromosomal P GAL1 -GST-prp8Daa1-78 allele that encodes Prp8p with the nonessential N-terminal proline-rich region (amino acids 1-78) missing, thereby allowing use of anti-8.6 antibodies 33 to detect only plasmid-encoded Prp8p. KL1 and KL3 cannot grow in glucose medium in the absence of plasmid-encoded PRP8, as the chromosomal PRP8 is strongly repressed. KL1 and KL3 were generated from BMA38a by one-step PCR gene replacement using pFA6a-kanMX6-pGAL1-GST or pFA6a-TrpMX6-pGAL1-GST as template 36 . Strains KL1-Snu114, KL1-Brr2p and KL1-Aar2p were derived from KL1, and KL3-Brr2p was derived from KL3 by one-step PCR 37 . The C terminus of PRP8 (encoding amino acids 2,173-2,413 plus 3HA tag) from pJU204 was cloned next to a hygromycin B marker (Hph r ) in pC8HH. By site-directed mutagenesis, two series of rp mutant plasmids were produced in pC8HH (pC8HH-rp1-pC8HH-rp7) and in pJU204 (pKL-rp5-pKL-rp7). The RP mutations were introduced into the genomic PRP8 locus of YCL46 (ref. 38 ) by one-step PCR from pC8HH plasmids using Hph r as marker. Images were obtained using a Leica DMRA2 microscope with CoolSnap HQ-cooled CCD camera (Roper Scientific) and LeicaFW400 software (Leica) 40, 41 .
RNA fluorescent in situ hybridization. The method was adapted from the Singer lab protocol (http://www.singerlab.org/protocols/insitu_yeast.htm). Yeast cells were grown in 36-ml cultures to early log phase (OD 600 between 0.2 and 0.4) and then fixed for 10 min at room temperature (21-23 1C) by directly adding to the medium 8 ml of 20% (v/v) formaldehyde, 50% (v/v) acetic acid. The fixative was removed by three rounds of washing with 10 ml ice-cold (0-4 1C) buffer B and centrifugation (5 min at 1,100g, 4 1C). Cells were spheroplasted as described above in the Microscopy section, centrifuged for 2 min at 1,100g and 4 1C, and washed once with ice-cold buffer B. Cells were resuspended in 500 ml of buffer B, and 100 ml was added to a poly-L-lysinecoated slide and left to adhere by incubating for 30 min at 4 1C. Slides were washed once with ice-cold buffer B and stored in 70% (v/v) ethanol at -20 1C. Hybridization: cells were rehydrated for 5 min in 2Â SSC (300 mM NaCl, 30 mM sodium citrate, pH 7.0) and 50% (v/v) formamide, then hybridized overnight at 37 1C in 40 ml of a mixture containing 10% (w/v) dextran sulfate, 0.02% (w/v) RNase-free bovine serum albumin (BSA), 40 mg Escherichia coli tRNA, 2Â SSC, 50% (v/v) formamide, 1 ml RNasin and 1 ml probe (10 ng). Cells were washed twice for 30 min in 2Â SSC, 50% (v/v) formamide at 37 1C (U2 probe) or 45 1C (U5 and U6 probes) and then mounted with Vectashield containing DAPI. The U2 FISH probe was as previously described 42 . U2, U5, and U6 FISH probes were 5¢ Cy3-modified oligos as listed in Supplementary Table 2 .
Immunoprecipitation, northern analysis and glycerol gradient fractionation. Yeast cell extracts were prepared 27 and splicing reactions were performed 43 using as substrate 32 P-labeled p283 (ACT1) transcript produced by in vitro transcription. Immunoprecipitation of snRNPs and spliceosomes was performed using rabbit anti-Prp8p polyclonal antibodies (anti-8.6 (ref. 33) ) and washes containing 150 mM NaCl. The immunoprecipitates were deproteinized by SDS/proteinase K treatment and phenol/chloroform/isoamyalcohol extraction, and the RNA was fractionated on a 6% polyacrylamide gel. 32 P-endlabeled oligonucleotides used to detect snRNAs in northern blotting are listed in Supplementary Table 2 . Levels of snRNAs were quantified using a Storm Phosphorimager (GE Healthcare).
Glycerol gradients were made and run essentially as described 44 . Briefly, splicing extracts (80 ml) were diluted with 120 ml GG buffer (20 mM HEPES at pH 7.0, 100 mM KCl, 0.2 mM EDTA; final glycerol concentration 8% (v/v)), sedimented through a 10%-30% (v/v) linear glycerol gradient at 243,000g for
